EFFECTS OF VIBEGRON ON AMBULATORY BLOOD PRESSURE IN PATIENTS WITH OVERACTIVE BLADDER: RESULTS FROM A DOUBLE-BLIND STUDY

被引：0
|
作者：
Weber, Michael A.
White, William B.
King, Jennifer
Walker, Ann
Mudd, Paul N., Jr.
Haag-Molkenteller, Cornelia
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 206卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD66-11
引用
收藏
页码：E1163 / E1163
页数：1
相关论文
共 50 条
  • [1] EFFECTS OF VIBEGRON ON AMBULATORY BLOOD PRESSURE IN PATIENTS WITH OVERACTIVE BLADDER: RESULTS FROM A DOUBLE-BLIND STUDY
    Weber, M.
    White, W.
    King, J.
    Walker, A.
    Mudd, Jr. P.
    Haag-Molkenteller, C.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2021, 40 : S95 - S96
  • [2] Effects of vibegron on ambulatory blood pressure in patients with overactive bladder: results from a double-blind, placebo-controlled trial
    Weber, Michael A.
    Haag-Molkenteller, Cornelia
    King, Jennifer
    Walker, Ann
    Mudd, Paul N., Jr.
    White, William B.
    [J]. BLOOD PRESSURE MONITORING, 2022, 27 (02) : 128 - 134
  • [3] A Randomized, Double-Blind, Placebo-Controlled, Bridging Study to Evaluate the Efficacy and Safety of Vibegron in Treating Korean Patients With Overactive Bladder
    Shin, Jung Hyun
    Jeong, Seong Jin
    Kim, Sun-Ouck
    Oh, Cheol Young
    Chung, Kyung Jin
    Shin, Dong Gil
    Kim, Tae Hyo
    Kwon, Joonbeom
    Shin, Ju-Hyun
    Bae, Woong Jin
    Lee, Kyu-Sung
    Choo, Myung-Soo
    [J]. INTERNATIONAL NEUROUROLOGY JOURNAL, 2023, 27 (02) : 106 - 115
  • [4] Efficacy and Safety of Vibegron for the Treatment of Overactive Bladder in Women: A Subgroup Analysis From the Double-Blind, Randomized, Controlled EMPOWUR Trial
    Newman, Diane K.
    Thomas, Elizabeth
    Greene, Heather
    Haag-Molkenteller, Cornelia
    Varano, Susann
    [J]. UROGYNECOLOGY, 2023, 29 (01): : 48 - 57
  • [5] Efficacy and Safety of Vibegron for the Treatment of Overactive Bladder in Women: A Subgroup Analysis From the Double-Blind, Randomized, Controlled EMPOWUR Trial
    Newman, Diane K.
    Thomas, Elizabeth
    Greene, Heather
    Haag-Molkenteller, Cornelia
    Varano, Susann
    [J]. OBSTETRICAL & GYNECOLOGICAL SURVEY, 2023, 78 (04) : 210 - 211
  • [6] International Phase III, Randomized, Double-Blind, Placebo and Active Controlled Study to Evaluate the Safety and Efficacy of Vibegron in Patients with Symptoms of Overactive Bladder: EMPOWUR
    Staskin, David
    Frankel, Jeffrey
    Varano, Susann
    Shortino, Denise
    Jankowich, Rachael
    Mudd, Paul N., Jr.
    [J]. JOURNAL OF UROLOGY, 2020, 204 (02): : 316 - 323
  • [7] ONCE-DAILY VIBEGRON 75 MG FOR OVERACTIVE BLADDER (OAB): DOUBLE-BLIND 52-WEEK RESULTS FROM AN EXTENSION STUDY OF THE INTERNATIONAL PHASE 3 TRIAL (EMPOWUR)
    Staskin, David
    Frankel, Jeffrey
    Varano, Susann
    Shortino, Denise
    Jankowich, Rachael
    Mudd, Paul
    [J]. JOURNAL OF UROLOGY, 2020, 203 : E453 - E453
  • [8] INTERNATIONAL PHASE 3, DOUBLE-BLIND, PLACEBO-AND ACTIVE (TOLTERODINE)-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF VIBEGRON IN PATIENTS WITH SYMPTOMS OF OVERACTIVE BLADDER: EMPOWUR
    Staskin, David
    Frankel, Jeffrey
    Varano, Susann
    Zhou, Jihao
    Jankowich, Rachael
    Mudd, Paul N.
    [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E992 - E992
  • [9] A DOUBLE-BLIND EVALUATION OF THE EFFECT OF AMLODIPINE ON AMBULATORY BLOOD-PRESSURE IN HYPERTENSIVE PATIENTS
    MROCZEK, WJ
    BURRIS, JF
    ALLENBY, KS
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 12 : S79 - S84
  • [10] Vibegron, a Novel Potent and Selective β3-Adrenoreceptor Agonist, for the Treatment of Patients with Overactive Bladder: A Randomized, Double-blind, Placebo-controlled Phase 3 Study
    Yoshida, Masaki
    Takeda, Masayuki
    Gotoh, Momokazu
    Nagai, Shinji
    Kurose, Takafumi
    [J]. EUROPEAN UROLOGY, 2018, 73 (05) : 783 - 790
12345